The Phase III clinical trial known as ADAPT, is a randomized, multicenter study that plans to enroll 450 patients overall, under an approved Special Protocol Assessment by the U.S. Food and Drug Administration. Stewart said he hopes to enroll at least 10 patients per year from Wake Forest Baptist.
For the third-straight year, the funds raised at Lift For Life reached record-setting heights.
76% lower incidence among those running more than 15 miles per week.
Hypertension has been repeatedly linked to renal cell cancer, independent of overweight and anti–hypertensive drug use, but its role remains unclear, especially within the growing group of relatively young–middle aged renal cancer patients.
“Our data appears to seriously question the assumption that by saving kidney tissue, we are helping patients avoid future kidney failure..."
A 58-year-old man was diagnosed as a hepatitis B virus (HBV) carrier approximately 30 years ago...
Mirati Therapeutics (MRTX), based in San Diego, CA is an early stage, oncology-focused company engaged in the development and commercialization of targeted therapies for patients with solid tumors...
Eliminating the charitable deduction would undermine significantly the ability of charitable organizations to do good work.
Calcified, minimally Fat-contained angiomyolipoma clinically indistinguishable from a renal cell carcinoma
Angiomyolipomas are benign tumors of the kidney.
Ensure an efficient and cost-effective national system rather than the current "patchwork quilt" of various state-by-state requirements.